Company has spent 1.06% of its operating revenues towards interest expenses and 5.63% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Rossari Biotech Share Price
Rossari Biotech Share P...
Rossari Biotech share price insights
Stock gave a 3 year return of -32.31% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Company has used Rs 103.21 cr for investing activities which is an YoY decrease of 42.94%. (Source: Consolidated Financials)
Rossari Biotech Ltd. share price moved down by -1.89% from its previous close of Rs 897.85. Rossari Biotech Ltd. stock last traded price is 880.95
Share Price Value Today/Current/Last 880.95 Previous Day 897.85
Key Metrics
PE Ratio (x) | 35.69 | ||||||||||
EPS - TTM (₹) | 24.68 | ||||||||||
MCap (₹ Cr.) | 4,867.03 | ||||||||||
Sectoral MCap Rank | 29 | ||||||||||
PB Ratio (x) | 4.73 | ||||||||||
Div Yield (%) | 0.06 | ||||||||||
Face Value (₹) | 2.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 890.26 | ||||||||||
52W H/L (₹) |
Rossari Biotech Share Price Returns
1 Day | -1.89% |
1 Week | -3.52% |
1 Month | 6.74% |
3 Months | 27.23% |
1 Year | 6.92% |
3 Years | -36.87% |
5 Years | N.A. |
Rossari Biotech Share Recommendations
Recent Recos
Current
Mean Recos by 5 Analysts
SellSellHoldBuyStrong
Buy
That's all for Rossari Biotech recommendations. Check out other stock recos.
Analyst Trends
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 3 |
Buy | 1 | 1 | 1 | 1 |
Hold | - | - | - | - |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 5 | 5 | 5 | 4 |
Rossari Biotech Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Employee & Interest Expense
Company has spent 1.06% of its operating revenues towards interest expenses and 5.63% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 490.60 473.11 467.27 484.83 412.80 Total Income Growth (%) 3.70 1.25 -3.62 17.45 0.86 Total Expenses 440.14 425.20 415.19 435.02 366.97 Total Expenses Growth (%) 3.51 2.41 -4.56 18.54 -0.25 EBIT 50.46 47.91 52.08 49.82 45.82 EBIT Growth (%) 5.33 -8.02 4.55 8.72 10.76 Profit after Tax (PAT) 34.90 34.13 34.39 32.95 29.22 PAT Growth (%) 2.25 -0.75 4.38 12.76 0.83 EBIT Margin (%) 10.29 10.13 11.15 10.28 11.10 Net Profit Margin (%) 7.11 7.21 7.36 6.80 7.08 Basic EPS (₹) 6.32 6.18 6.23 5.97 5.30 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 1,572.15 1,367.57 1,256.72 561.35 471.52 Total Assets Growth (%) 14.96 8.82 123.88 19.05 88.72 Total Liabilities 524.42 452.40 451.56 152.58 184.84 Total Liabilities Growth (%) 15.92 0.19 195.96 -17.45 46.66 Total Equity 1,047.73 915.17 805.16 408.77 286.19 Total Equity Growth (%) 14.49 13.66 96.97 42.83 131.15 Current Ratio (x) 1.99 2.08 2.07 2.36 2.19 Total Debt to Equity (x) 0.10 0.08 0.01 0.00 0.21 Contingent Liabilities 0.00 19.96 2.61 5.13 21.23 All figures in Rs Cr, unless mentioned otherwise
Insights
Cash from Operations vs PAT
Operating cash flow of Rs 43.26 cr is 0.33 times compared to the reported net profit of Rs 130.69 cr. (Source: Consolidated Financials)Decrease in Cash from Investing
Company has used Rs 103.21 cr for investing activities which is an YoY decrease of 42.94%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 43.26 152.39 29.36 47.77 56.83 Net Cash used in Investing Activities -103.21 -180.89 -298.88 -37.18 -190.30 Net Cash flow from Financing Activities 16.19 60.86 291.79 -24.59 156.94 Net Cash Flow -44.03 32.36 22.27 -14.00 23.47 Closing Cash & Cash Equivalent 25.17 69.83 37.48 15.21 29.21 Closing Cash & Cash Equivalent Growth (%) -63.96 86.33 146.43 -47.94 408.73 Total Debt/ CFO (x) 2.45 0.49 0.29 0.00 1.07 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 12.47 11.71 12.13 19.62 22.80 Return on Capital Employed (%) 17.15 16.22 15.31 26.61 28.38 Return on Assets (%) 8.31 7.84 7.77 14.29 13.83 Interest Coverage Ratio (x) 13.28 10.24 15.44 36.57 25.76 Asset Turnover Ratio (x) 1.25 0.82 1.44 126.36 127.26 Price to Earnings (x) 28.57 30.67 51.55 67.57 - Price to Book (x) 3.56 3.59 6.25 13.18 - EV/EBITDA (x) 14.78 14.15 25.51 40.08 - EBITDA Margin (%) 14.05 13.79 13.17 18.64 18.07
Rossari Biotech Peer Comparison
Rossari Biotech Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -32.31% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -32.31% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Rossari Biotech Board Meeting/AGM
Rossari Biotech Dividends
- Others
Meeting Date Announced on Purpose Details Jul 20, 2024 Jul 12, 2024 Board Meeting Quarterly Results Apr 29, 2024 Apr 22, 2024 Board Meeting Audited Results & Final Dividend Jan 20, 2024 Jan 12, 2024 Board Meeting Quarterly Results Dec 08, 2023 Nov 09, 2023 POM - Oct 21, 2023 Oct 13, 2023 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 25% 0.5 Aug 16, 2024 Apr 29, 2024 Final 25% 0.5 May 24, 2023 May 02, 2023 Final 25% 0.5 Jul 07, 2022 May 20, 2022 Final 25% 0.5 Sep 08, 2021 May 14, 2021 No other corporate actions details are available.
About Rossari Biotech
Rossari Biotech Ltd., incorporated in the year 2009, is a Small Cap company (having a market cap of Rs 4,960.39 Crore) operating in Chemicals sector. Rossari Biotech Ltd. key Products/Revenue Segments include Organic/Inorganic Heavy Chemicals, Commission and Other Operating Revenue for the year ending 31-Mar-2023. Show More
Executives
Auditors
- EM
Edward Menezes
Executive ChairmanSCSunil Chari
Managing DirectorASAparna Sharma
Independent DirectorADAseem Dhru
Independent DirectorShow More - Walker Chandiok & Co. LLPDeloitte Haskins & Sells LLP
Industry
Key Indices Listed on
BSE SmallCap, BSE Commodities, BSE AllCap, + 4 more
Address
201 A-B, 2nd Floor,Akruti Corporate Park,L.B.S. Marg, Next to GE Gardens,Mumbai, Maharashtra - 400078
More Details
Trending in Markets
Rossari Biotech Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.